Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
2007 1
2008 1
2009 1
2010 3
2011 3
2012 1
2014 2
2015 3
2016 3
2017 11
2018 6
2019 4
2020 5
2021 3
2022 5
2023 2
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

49 results

Results by year

Filters applied: . Clear all
Page 1
Role of Machine Learning (ML)-Based Classification Using Conventional 18F-FDG PET Parameters in Predicting Postsurgical Features of Endometrial Cancer Aggressiveness.
Bezzi C, Bergamini A, Mathoux G, Ghezzo S, Monaco L, Candotti G, Fallanca F, Gajate AMS, Rabaiotti E, Cioffi R, Bocciolone L, Gianolli L, Taccagni G, Candiani M, Mangili G, Mapelli P, Picchio M. Bezzi C, et al. Among authors: fallanca f. Cancers (Basel). 2023 Jan 3;15(1):325. doi: 10.3390/cancers15010325. Cancers (Basel). 2023. PMID: 36612321 Free PMC article.
Predictive value on advance hodgkin lymphoma treatment outcome of end-of treatment FDG PET/CT in the HD0607 clinical trial.
Biggi A, Chauvie S, Fallanca F, Guerra L, Bergesio F, Menga M, Bianchi A, Gregianin M, Chiaravalloti A, Schillaci O, Pavoni C, Patti C, Picardi M, Romano A, Schiavotto C, Sorasio R, Viviani S, La Nasa G, Trentin L, Rambaldi A, Gallamini A. Biggi A, et al. Among authors: fallanca f. Hematol Oncol. 2023 Aug;41(3):415-423. doi: 10.1002/hon.3117. Epub 2023 Jan 4. Hematol Oncol. 2023. PMID: 36534947 Clinical Trial.
Decoding the Heterogeneity of Malignant Gliomas by PET and MRI for Spatial Habitat Analysis of Hypoxia, Perfusion, and Diffusion Imaging: A Preliminary Study.
Bailo M, Pecco N, Callea M, Scifo P, Gagliardi F, Presotto L, Bettinardi V, Fallanca F, Mapelli P, Gianolli L, Doglioni C, Anzalone N, Picchio M, Mortini P, Falini A, Castellano A. Bailo M, et al. Among authors: fallanca f. Front Neurosci. 2022 Jul 13;16:885291. doi: 10.3389/fnins.2022.885291. eCollection 2022. Front Neurosci. 2022. PMID: 35911979 Free PMC article.
18F-FDG PET/CT May Predict Tumor Type and Risk Score in Gestational Trophoblastic Disease.
Bezzi C, Monaco L, Ghezzo S, Mathoux G, Bergamini A, Zambella E, Fallanca F, Samanes Gajate AM, Presotto L, Sabetta G, Mangili G, Cioffi R, Bettinardi V, Gianolli L, Mapelli P, Picchio M. Bezzi C, et al. Among authors: fallanca f. Clin Nucl Med. 2022 Jun 1;47(6):525-531. doi: 10.1097/RLU.0000000000004135. Epub 2022 Mar 30. Clin Nucl Med. 2022. PMID: 35353763
Hybrid PET/MRI in Staging Endometrial Cancer: Diagnostic and Predictive Value in a Prospective Cohort.
Ironi G, Mapelli P, Bergamini A, Fallanca F, Candotti G, Gnasso C, Taccagni GL, Sant'Angelo M, Scifo P, Bezzi C, Bettinardi V, Rancoita PMV, Mangili G, Bocciolone L, Candiani M, Gianolli L, De Cobelli F, Picchio M. Ironi G, et al. Among authors: fallanca f. Clin Nucl Med. 2022 Mar 1;47(3):e221-e229. doi: 10.1097/RLU.0000000000004064. Clin Nucl Med. 2022. PMID: 35067539
A Prospective Observational Study on the Efficacy and Safety of Infliximab-Biosimilar (CT-P13) in Patients With Takayasu Arteritis (TAKASIM).
Campochiaro C, Tomelleri A, Sartorelli S, Sembenini C, Papa M, Fallanca F, Picchio M, Cavalli G, De Cobelli F, Baldissera E, Dagna L. Campochiaro C, et al. Among authors: fallanca f. Front Med (Lausanne). 2021 Sep 27;8:723506. doi: 10.3389/fmed.2021.723506. eCollection 2021. Front Med (Lausanne). 2021. PMID: 34646844 Free PMC article.
18F-FAZA PET/CT in pretreatment assessment of hypoxic status in high-grade glioma: correlation with hypoxia immunohistochemical biomarkers.
Mapelli P, Callea M, Fallanca F, Castellano A, Bailo M, Scifo P, Bettinardi V, Conte GM, Monterisi C, Rancoita PMV, Incerti E, Vuozzo M, Gianolli L, Terreni M, Anzalone N, Picchio M. Mapelli P, et al. Among authors: fallanca f. Nucl Med Commun. 2021 Jul 1;42(7):763-771. doi: 10.1097/MNM.0000000000001396. Nucl Med Commun. 2021. PMID: 33741855
Consolidation Radiotherapy Could Be Safely Omitted in Advanced Hodgkin Lymphoma With Large Nodal Mass in Complete Metabolic Response After ABVD: Final Analysis of the Randomized GITIL/FIL HD0607 Trial.
Gallamini A, Rossi A, Patti C, Picardi M, Romano A, Cantonetti M, Oppi S, Viviani S, Bolis S, Trentin L, Gini G, Battistini R, Chauvie S, Sorasio R, Pavoni C, Zanotti R, Cimminiello M, Schiavotto C, Viero P, Mulé A, Fallanca F, Ficola U, Tarella C, Guerra L, Rambaldi A. Gallamini A, et al. Among authors: fallanca f. J Clin Oncol. 2020 Nov 20;38(33):3905-3913. doi: 10.1200/JCO.20.00935. Epub 2020 Sep 18. J Clin Oncol. 2020. PMID: 32946355 Clinical Trial.
49 results